Disclosed is a polyethylene glycolated (PEGylated) C-peptide as defined in the complete specification. The disclosed peptide is used in the treatment of reducing the risk of hypoglycaemia in a human patient with insulin dependent diabetes and in the treatment of long-term complications of diabetes.